Endometrial hyperplasia screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Endometrial hyperplasia}} | {{Endometrial hyperplasia}} | ||
{{CMG}}{{AE}} {{STM}} | |||
==Oveview== | |||
Routine screening for endometrial hyperplasia or endometrial carcinoma is not recommended. | |||
==Screening== | |||
Routine screening for endometrial hyperplasia or endometrial carcinoma is not recommended. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 9: | Line 15: | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 16:00, 9 March 2016
|
Endometrial hyperplasia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Endometrial hyperplasia screening On the Web |
|
American Roentgen Ray Society Images of Endometrial hyperplasia screening |
|
Risk calculators and risk factors for Endometrial hyperplasia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]
Oveview
Routine screening for endometrial hyperplasia or endometrial carcinoma is not recommended.
Screening
Routine screening for endometrial hyperplasia or endometrial carcinoma is not recommended.